Cvs Pharmacy Glycerin

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the short-term relief of constipation. It is recommended that laxative products not be used for longer than one week unless directed by a healthcare professional.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 6 years and older, the recommended dosage is one suppository per day, or as directed by a healthcare professional. For children aged 2 to under 6 years, CVS/pharmacy™ Child Suppositories should be utilized. In the case of children under 2 years of age, it is advised to consult a doctor prior to administration.

The administration method involves inserting one suppository well up into the rectum. It is important for the patient to retain the suppository for a minimum of 15 minutes to ensure effective laxative action. Notably, the suppository does not need to melt in order to produce the desired laxative effect.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

For rectal use only. It is imperative that healthcare professionals advise patients to adhere strictly to this route of administration to ensure safety and efficacy.

Patients should be instructed to consult a physician prior to use if they experience any of the following conditions: abdominal pain, nausea, vomiting, or a sudden change in bowel habits lasting more than two weeks. These symptoms may indicate underlying issues that require medical evaluation.

In the event of rectal bleeding or failure to have a bowel movement after the use of a laxative, patients must discontinue use immediately and seek medical advice. These symptoms could signify a serious medical condition that necessitates further investigation.

If the product is ingested, it is crucial to obtain emergency medical assistance or contact a Poison Control Center without delay. Prompt action is essential in such cases to mitigate potential health risks.

Side Effects

Patients should be aware that the product is intended for rectal use only. Prior to using this medication, it is advisable for patients to consult a healthcare professional if they experience abdominal pain, nausea, vomiting, or a sudden change in bowel habits lasting more than two weeks.

In the event of rectal bleeding or failure to have a bowel movement after using the laxative, patients should discontinue use and seek medical advice, as these symptoms may indicate a serious underlying condition.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Pharmacy Glycerin (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 to under 6 years should use CVS/pharmacy™ Child Suppositories. For infants and children under 2 years, it is advised to consult a doctor before use. In patients aged 6 years and older, the recommended dosage is 1 suppository per day or as directed by a healthcare professional.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may require dosage adjustments due to reduced renal function. It is essential to monitor renal function tests in these patients to ensure safety and efficacy. A reduced dose should be considered for patients with a creatinine clearance below a specified threshold. Additionally, special monitoring is necessary for patients with severe renal impairment to mitigate potential risks associated with treatment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Consultation: Engage with a poison control center or toxicology expert for guidance on specific antidotes or additional management strategies tailored to the substance involved.

It is imperative to monitor the patient closely for any evolving symptoms and to provide symptomatic treatment as required. Documentation of the incident and any interventions performed should be meticulously recorded for future reference and quality assurance.

In summary, while specific overdosage information is not available, healthcare professionals should be prepared to act swiftly and effectively in managing potential overdose situations, ensuring patient safety and optimal outcomes.

Nonclinical Toxicology

There is no information available regarding teratogenic effects. For individuals who are pregnant or breastfeeding, it is advised to consult a health professional prior to use. Additionally, no data has been provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Healthcare providers should encourage patients to consult with a doctor prior to using the product if they experience any of the following symptoms: abdominal pain, nausea, vomiting, or a sudden change in bowel habits that persists for more than two weeks.

Additionally, patients should be instructed to discontinue use and consult a doctor if they encounter rectal bleeding or if they do not have a bowel movement after using a laxative. These symptoms may indicate a serious underlying condition that requires medical evaluation.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. Currently, there are no specified storage or handling conditions provided. It is recommended that healthcare professionals refer to the product's labeling for any additional information regarding supply and storage requirements.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cvs Pharmacy Glycerin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)